FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting
University of L'Aquila · National Institutes of Health · +3 more institutions
Abstract
FGF-23, a novel member of the FGF family, is the product of the gene mutated in autosomal dominant hypophosphatemic rickets (ADHR). FGF-23 has been proposed as a circulating factor causing renal phosphate wasting not only in ADHR (as a result of inadequate degradation), but also in tumor-induced osteomalacia (as a result of excess synthesis by tumor cells). Renal phosphate wasting occurs in approximately 50% of patients with McCune-Albright syndrome (MAS) and fibrous dysplasia of bone (FD), which result from postzygotic mutations of the GNAS1 gene. We found that FGF-23 is produced by normal and FD osteoprogenitors and bone-forming cells in vivo and in vitro. In situ hybridization analysis of FGF-23 mRNA…
Citation impact
- FWCI
- 14.98
- Percentile
- 100%
- References
- 47
Authors
12Topics & keywords
- Fibrous dysplasia
- Osteomalacia
- Wasting
- Fibroblast growth factor 23
- Internal medicine
- Endocrinology
- GNAS complex locus
- Bone disease
- Good health and well-being